Table 1 Correlation between Lipoxins Effect Score (LES) and Clinical Pathological Features in Pancreatic Cancer
Sample (n) | Lipoxins Effect Score (LES) | |||
|---|---|---|---|---|
Low LES (%) | High LES (%) | P Value∆ | ||
Gender | 0.295 | |||
Male | 39 | 21 (53.8) | 18 (46.2) | |
Female | 27 | 11 (40.7) | 16 (59.3) | |
Age | 0.622 | |||
< 56.50† | 33 | 15 (45.5) | 18 (54.5) | |
≥ 56.50 | 33 | 17 (51.5) | 16 (48.5) | |
Types | 1.000 | |||
Ductal Adenocarcinoma | 62 | 30 (48.4) | 32 (51.6) | |
Other Types | 4 | 2 (50.0) | 2 (50.0) | |
Histological Grade | 0.029* | |||
1 | 20 | 6 (30.0) | 14 (70.0) | |
2 | 23 | 10 (43.5) | 13 (56.5) | |
3 | 23 | 16 (69.6) | 7 (30.4) | |
pT Status | 0.030* | |||
T1 | 3 | 0 (0.0) | 3 (100.0) | |
T2 | 21 | 7 (33.3) | 14 (66.7) | |
T3 | 39 | 22 (56.4) | 17 (43.6) | |
T4 | 3 | 3 (100) | 0 (0.0) | |
pN Status | 0.008* | |||
N0 | 54 | 22 (40.7) | 32 (59.3) | |
N1 | 12 | 10 (83.3) | 2 (16.7) | |
pM Status | 0.026* | |||
M0 | 60 | 26 (43.3) | 34 (56.7) | |
M1 | 6 | 6 (100.0) | 0 (0.0) | |
TNM Stage (AJCC) | 0.002* | |||
I | 19 | 4 (21.1) | 15 (78.9) | |
II | 32 | 15 (46.9) | 17 (53.1) | |
III | 9 | 7 (77.8) | 2 (22.2) | |
IV | 6 | 6 (100.0) | 0 (0.0) | |